WHITEFISH, MT / ACCESSWIRE / March 31, 2014 / TDM Financial, a leading financial network covering new, emerging and established companies across many different industry verticals, today announced that Medican Enterprises, Inc. (OTCBB: MDCN) has engaged its services. Medican Enterprises is a biopharmaceutical company focused on developing, distributing and marketing pharmaceutical grade cannabis to the emerging global medical marijuana market.
“We are committed to transparently building a diverse and balanced shareholder base,” said Medican Enterprises Inc. CEO Ken Williams. “TDM Financial enables us to enhance communications with individual and institutional investors interested in the medical marijuana space through fully-compliant and high-quality coverage on mainstream and industry-specific financial websites.”
Medican Enterprises, Inc.’s wholly owned subsidiary Medican Systems, Inc. is an industry leader in the design, construction and operation of Medical Marijuana and Cultivation Centers across Canada. Medican Enterprises drives shareholder value through its scalable business model and commitment to scientific research, operational excellence and regulatory compliance.
“The U.S. market for legal marijuana is expected to grow from $2.3 billion in 2014 to $10.2 billion over the next five years according to ArcView Market Research,” said TDM Financial President Daniel Minton. “We are excited to be working with Medican Enterprises as it aims to become a leading medical marijuana supplier through joint venture partnerships and its unique team.”
About TDM Financial:
TDM Financial is a dedicated financial networking covering new, emerging and established companies across many different industry verticals. Its flagship property, SECFilings.com, is a leading destination for sophisticated investors looking to track and analyze regulatory filings with the SEC with over 600,000 registered members receiving real-time e-mail alerts on companies they follow.
About Medican Enterprises, Inc.
Forward-Looking and Cautionary Statements: